WEBSITECHANGES

Website Changes

---

01/17/2018

Midatech and UCSF receive IND approval for DIPG treatment MTX110

---

01/17/2018

Help Us Understand Glioblastoma Multiforme (GBM) Patient Experiences better through a quick survey:

---

01/17/2018

Long Island resident with recurrent brain cancer receives novel experimental treatment at Lenox Hill Hospital

---

01/11/2018

Drugs targeting the cells circadian rhythm offers hope for glioblastoma

---

01/10/2018

Dr. Kurt Jaeckle to Lead Phase III Clinical Trial of Novel Drug VAL-083 for Late-Stage Glioblastoma

---

01/08/2018

Study Finds Growing Socioeconomic and Racial Disparities in Management of Brain Metastases

---

01/06/2018

Help Us Understand Glioblastoma Multiforme (GBM) Patient Experiences better through a quick survey:

---

01/05/2018

Bettye J. Wiley Hooks shares lessons of own battle with cancer

---

12/29/2017

Musella Foundation awards brain tumor research grant!

---

12/29/2017

Charitable giving to take a hit from the tax law

---

12/28/2017

Foundation Aims For Virtual Trial Registry To Help Patients With Brain Cancer Get Drugs Sooner

---

12/27/2017

Cancer Drug Price Rises 1,400% With No Generic to Challenge It

---

12/27/2017

Diffusion Pharmaceuticals Begins Phase 3 Clinical Trial with TSC in Glioblastoma Multiforme

---

12/26/2017

DelMar Pharmaceuticals announces Fast Track designation for VAL-083 in recurrent Glioblastoma

---

12/23/2017

Musella Foundation awards brain tumor research grant!

---

12/23/2017

Musella Foundation Co-pay Assistance Program Status

---

12/23/2017

Highlights from the Society for Neuro Oncology annual meeting, San Francisco California, November 16-19 2017

---

12/19/2017

JAMA Publishes Final Analysis of EF-14 Phase 3 Pivotal Trial of Optune® Together with Temozolomide Demonstrating Unprecedented Survival Results for Newly Diagnosed Glioblastoma

---

12/07/2017

Recurrent glioma clinical trial, CheckMate-143: the game is not over yet

---

12/06/2017

FDA Grants Genentech’s Avastin Full Approval for Most Aggressive Form of Brain Cancer

---

12/04/2017

A novel immuno-oncology approach to treating a rare childhood brain cancer

---

12/03/2017

Tumor response of temozolomide in combination with morphine in a xenograft model of human glioblastoma.

---

12/03/2017

Correction regarding dose of Avastin in an old article

---

12/02/2017

Promising target for treating brain tumors in children

---

12/02/2017

Novocure (NVCR) Announces Reimbursement Approval for Optune in Japan for Treatment of Newly Diagnosed GBM

---